| Date Filed | Type | Description |
| 05/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMN HEALTHCARE SERVICES INC|
Txns:
| Exercised 1,681 restricted stock units
@ $0 |
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2023 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMN HEALTHCARE SERVICES INC|
Txns:
| Exercised 2,139 restricted stock units
@ $0
Granted 1,458 restricted stock units
@ $0 |
|
| 03/07/2022 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $68.22, valued at
$511.7k
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2021 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 45 shares
@ $615.13, valued at
$27.7k
Sold 14 shares
@ $619.32, valued at
$8.7k
Sold 13 shares
@ $622.625, valued at
$8.1k
Sold 43 shares
@ $624.097, valued at
$26.8k
Sold 124 shares
@ $625.3187, valued at
$77.5k
Sold 7 shares
@ $626.045, valued at
$4.4k
Sold 56 shares
@ $627.7946, valued at
$35.2k
Sold 76 shares
@ $628.4074, valued at
$47.8k
Sold 42 shares
@ $629.33, valued at
$26.4k
Sold 40 shares
@ $631.26, valued at
$25.3k
Sold 40 shares
@ $634.01, valued at
$25.4k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $49.92, valued at
$374.4k
|
|
| 11/18/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 15 shares
@ $336.9807, valued at
$5.1k
Sold 139 shares
@ $337.78, valued at
$47k
Sold 117 shares
@ $340.2339, valued at
$39.8k
Sold 428 shares
@ $341.786, valued at
$146.3k
Sold 301 shares
@ $342.929, valued at
$103.2k
|
|
| 10/19/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 42 shares
@ $391.4843, valued at
$16.4k
Sold 120 shares
@ $395.02, valued at
$47.4k
Sold 255 shares
@ $396.5065, valued at
$101.1k
Sold 375 shares
@ $397.4136, valued at
$149k
Sold 208 shares
@ $398.2472, valued at
$82.8k
|
|
| 09/16/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 3 shares
@ $386.21, valued at
$1.2k
Sold 109 shares
@ $390.858, valued at
$42.6k
Sold 200 shares
@ $391.9484, valued at
$78.4k
Sold 231 shares
@ $393.7281, valued at
$91k
Sold 222 shares
@ $395.2821, valued at
$87.8k
Sold 121 shares
@ $396.1669, valued at
$47.9k
Sold 114 shares
@ $397.7518, valued at
$45.3k
|
|
| 07/01/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 17,000 options to buy
@ $49.04, valued at
$833.7k
|
|
| 07/01/2020 |
3
| FOLETTA MARK G (Director) has filed a Form 3 on ENANTA PHARMACEUTICALS INC |
| 05/27/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed of 3,055 shares
@ $0
Granted 895 shares
@ $0.001, valued at
$0.9
Acquired 3,055 shares
@ $0 |
|
| 04/24/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMN HEALTHCARE SERVICES INC|
Txns:
| Granted 2,826 restricted stock units
@ $0 |
|
| 04/21/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMN HEALTHCARE SERVICES INC|
Txns:
| Exercised 2,907 restricted stock units
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 301 shares
@ $236.8447, valued at
$71.3k
Sold 524 shares
@ $238.0467, valued at
$124.7k
Sold 166 shares
@ $238.8564, valued at
$39.7k
Sold 9 shares
@ $240.6767, valued at
$2.2k
|
|
| 01/07/2020 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 528 shares
@ $217.612, valued at
$114.9k
Sold 339 shares
@ $218.3933, valued at
$74k
Sold 133 shares
@ $218.9355, valued at
$29.1k
|
|
| 12/05/2019 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 3 shares
@ $221.34, valued at
$664
Sold 70 shares
@ $223.41, valued at
$15.6k
Sold 232 shares
@ $226.2002, valued at
$52.5k
Sold 233 shares
@ $227.6637, valued at
$53k
Sold 462 shares
@ $228.9318, valued at
$105.8k
|
|
| 10/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed of 4,052 shares
@ $0
Acquired 4,052 shares
@ $0
Granted 3,055 shares
@ $0.001, valued at
$3.1 |
|
| 05/29/2019 |
4
| FOLETTA MARK G (EVP & CFO) has filed a Form 4 on Tocagen Inc|
Txns:
| Bought 5,000 shares
@ $4.295, valued at
$21.5k
|
|
| 05/17/2019 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 100 shares
@ $118.65, valued at
$11.9k
Sold 500 shares
@ $121.878, valued at
$60.9k
Sold 400 shares
@ $122.7263, valued at
$49.1k
|
|
| 04/19/2019 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMN HEALTHCARE SERVICES INC|
Txns:
| Exercised 2,153 restricted stock units
@ $0
Granted 2,907 restricted stock units
@ $0 |
|
| 04/17/2019 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 100 shares
@ $116.96, valued at
$11.7k
Sold 301 shares
@ $118.8837, valued at
$35.8k
Sold 599 shares
@ $119.3599, valued at
$71.5k
|
|
|